Aemetis, Inc (NASDAQ:AMTX)‘s stock had its “hold” rating reaffirmed by B. Riley in a research report issued to clients and investors on Monday. They currently have a $2.00 target price on the specialty chemicals company’s stock. B. Riley’s price objective indicates a potential upside of 159.74% from the company’s current price.

Other research analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Tuesday, October 17th. FBR & Co restated a “neutral” rating and set a $2.00 price target on shares of Aemetis in a research note on Saturday, August 19th.

Aemetis (NASDAQ AMTX) traded up $0.06 during trading on Monday, reaching $0.77. 40,000 shares of the company’s stock traded hands, compared to its average volume of 50,472. The company has a debt-to-equity ratio of -1.87, a quick ratio of 0.20 and a current ratio of 0.37. Aemetis has a 52-week low of $0.53 and a 52-week high of $2.50.

TRADEMARK VIOLATION WARNING: This piece was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/11/13/aemetis-inc-amtx-rating-reiterated-by-b-riley.html.

A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC boosted its holdings in shares of Aemetis, Inc (NASDAQ:AMTX) by 3.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 1,562,431 shares of the specialty chemicals company’s stock after acquiring an additional 50,800 shares during the period. Geneva Advisors LLC owned 7.93% of Aemetis worth $2,078,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 18.71% of the company’s stock.

About Aemetis

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with MarketBeat.com's FREE daily email newsletter.